- 专利标题： COMPOSITION FOR ENHANCING COGNITIVE FUNCTION, COMPOSITION FOR REMEDYING ANXIETY SYMPTOMS, AND COMPOSITION FOR SUPPRESSING CEREBRAL ATROPHY
-
申请号： EP19764416.4申请日： 2019-03-05
-
公开(公告)号： EP3763363A1公开(公告)日： 2021-01-13
- 发明人: SATO, Hideaki , YASUI, Masako , ADACHI, Yusuke , SUZUKI, Katsuya , TAKADA, Michihiro
- 申请人： AJINOMOTO CO., INC.
- 申请人地址： JP Chuo-ku Tokyo 104-8315 15-1, Kyobashi 1-chome
- 代理机构： Strehl Schübel-Hopf & Partner
- 优先权： JP2018038950 20180305
- 国际公布： WO2019172287 20190912
- 主分类号： A61K31/198
- IPC分类号： A61K31/198 ; A23L33/175 ; A61K31/405 ; A61K31/4172 ; A61P25/22 ; A61P25/28
摘要：
The present invention provides a composition for improving cognitive function, a composition for improving anxiety-like symptoms, and a composition for suppressing cerebral atrophy containing one or more kinds selected from the group consisting of 25 mol% - 45 mol% of leucine, and 20 mol% - 40 mol% of phenylalanine relative to the total content of leucine, lysine, valine, isoleucine, phenylalanine, histidine and tryptophan, which are highly safe and can be ingested or administered continuously.
信息查询
IPC分类:
